Kyoto Prefectural University of Medicine · Faculty of Medicine

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study.
• Maximum home blood pressure and cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study.
• Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study).
• 収縮期血圧の最大値は2型糖尿病における心血管イベント新規発症の予測因子となりうる

• バセドウ病での甲状腺浸潤自己反応性T細胞の空間トランスクリプトーム解析

• Official profile
• ORCID